Carbocysteines in the current therapy of lung diseases in children
The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical a...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2016-11-01
|
Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
Subjects: | |
Online Access: | https://www.ped-perinatology.ru/jour/article/view/374 |
_version_ | 1797875314827722752 |
---|---|
author | Yu. L. Mizernitsky |
author_facet | Yu. L. Mizernitsky |
author_sort | Yu. L. Mizernitsky |
collection | DOAJ |
description | The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical and immunological efficacies as a mucoregulatory and mucolytic agent used in children aged 2 to 17 years with acute and chronic bronchopulmonary diseases. The highest efficacy of carbocysteine lysine salt has been found in schoolchildren, which is attributable to the age-related features of the formation of the bronchial secretory apparatus and local immune system, as well as in the children with protracted and chronic inflammatory processes, including those associated with smoking. |
first_indexed | 2024-04-10T01:44:37Z |
format | Article |
id | doaj.art-855a50b92db74b608c0e2f947fc3bbfb |
institution | Directory Open Access Journal |
issn | 1027-4065 2500-2228 |
language | Russian |
last_indexed | 2024-04-10T01:44:37Z |
publishDate | 2016-11-01 |
publisher | Ltd. “The National Academy of Pediatric Science and Innovation” |
record_format | Article |
series | Rossijskij Vestnik Perinatologii i Pediatrii |
spelling | doaj.art-855a50b92db74b608c0e2f947fc3bbfb2023-03-13T09:12:42ZrusLtd. “The National Academy of Pediatric Science and Innovation”Rossijskij Vestnik Perinatologii i Pediatrii1027-40652500-22282016-11-01615192210.21508/1027-4065-2016-61-5-19-22353Carbocysteines in the current therapy of lung diseases in childrenYu. L. Mizernitsky0ОСП «Научно-исследовательский клинический институт педиатрии имени академика Ю.Е. Вельтищева» ГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РФ, МоскваThe paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical and immunological efficacies as a mucoregulatory and mucolytic agent used in children aged 2 to 17 years with acute and chronic bronchopulmonary diseases. The highest efficacy of carbocysteine lysine salt has been found in schoolchildren, which is attributable to the age-related features of the formation of the bronchial secretory apparatus and local immune system, as well as in the children with protracted and chronic inflammatory processes, including those associated with smoking.https://www.ped-perinatology.ru/jour/article/view/374детимукоактивная терапиямукорегуляторыкарбоцистеина лизиновая сольфлуифорт |
spellingShingle | Yu. L. Mizernitsky Carbocysteines in the current therapy of lung diseases in children Rossijskij Vestnik Perinatologii i Pediatrii дети мукоактивная терапия мукорегуляторы карбоцистеина лизиновая соль флуифорт |
title | Carbocysteines in the current therapy of lung diseases in children |
title_full | Carbocysteines in the current therapy of lung diseases in children |
title_fullStr | Carbocysteines in the current therapy of lung diseases in children |
title_full_unstemmed | Carbocysteines in the current therapy of lung diseases in children |
title_short | Carbocysteines in the current therapy of lung diseases in children |
title_sort | carbocysteines in the current therapy of lung diseases in children |
topic | дети мукоактивная терапия мукорегуляторы карбоцистеина лизиновая соль флуифорт |
url | https://www.ped-perinatology.ru/jour/article/view/374 |
work_keys_str_mv | AT yulmizernitsky carbocysteinesinthecurrenttherapyoflungdiseasesinchildren |